2withQ: The Future of Dried Blood Spot Testing
1:31
2withQ: The Future of Dried Blood Spot Testing
2withQ: How Blood Spot Tests Could Change the Patient Journey from Diagnosis to Care
2:23
2withQ: How Blood Spot Tests Could Change the Patient Journey from Diagnosis to Care
2withQ: The Biochemical and Pathologic Differences of pTau 205 and pTau 212
1:46
2withQ: The Biochemical and Pathologic Differences of pTau 205 and pTau 212
2withQ: Quanterix's Role in Biomarker Testing Evolution with Jorge Marques Signes
2:20
2withQ: Quanterix's Role in Biomarker Testing Evolution with Jorge Marques Signes
2withQ: p-Tau 205 and p-Tau 212's Role in the Future of Diagnostics and Clinical Trials
1:57
2withQ: p-Tau 205 and p-Tau 212's Role in the Future of Diagnostics and Clinical Trials
2withQ: Dr. Nick Ashton on Building an NPTX2 Synaptic Biomarker Assay (Part 2)
2:40
2withQ: Dr. Nick Ashton on Building an NPTX2 Synaptic Biomarker Assay (Part 2)
2withQ: Dr. Nick Ashton on Building an NPTX2 Synaptic Biomarker Assay (Part 1)
2:53
2withQ: Dr. Nick Ashton on Building an NPTX2 Synaptic Biomarker Assay (Part 1)
Simoa Technology
1:07
Simoa Technology
2withQ: Inside the Development of pTau 205 & 212
1:51
2withQ: Inside the Development of pTau 205 & 212
2withQ: Ensuring Biomarker Testing Reliability and Regulatory Compliance with Jorge Marques Signes
2:49
2withQ: Ensuring Biomarker Testing Reliability and Regulatory Compliance with Jorge Marques Signes
2withQ: Enabling the Clinical Trial Life Cycle with a Fit-for-Purpose Approach with Jorge Signes
1:59
2withQ: Enabling the Clinical Trial Life Cycle with a Fit-for-Purpose Approach with Jorge Signes
Advanced Blood Biomarker Detection: SIMOA and the Future of Dementia Diagnosis with Danilo La Terra
28:04
Advanced Blood Biomarker Detection: SIMOA and the Future of Dementia Diagnosis with Danilo La Terra
10 Years of Super-Sensitive Blood Biomarker Research at the UCL Fluid Biomarker Laboratory
24:08
10 Years of Super-Sensitive Blood Biomarker Research at the UCL Fluid Biomarker Laboratory
2withQ: Optimizing NfL Detection in Mouse Models with Wes Straub
1:44
2withQ: Optimizing NfL Detection in Mouse Models with Wes Straub
Innovating Parkinson's Disease Research: Dartmouth Geisel School of Medicine
2:10
Innovating Parkinson's Disease Research: Dartmouth Geisel School of Medicine
Webinar Highlight-How to create efficiency & effectiveness in EU IVDR Readiness for clinical studies
0:34
Webinar Highlight-How to create efficiency & effectiveness in EU IVDR Readiness for clinical studies
Fireside Chat & Networking Reception | CTAD 2024
41:01
Fireside Chat & Networking Reception | CTAD 2024
Highlight: Fireside Chat with Dr. Henrik Zetterberg | CTAD 2024
6:16
Highlight: Fireside Chat with Dr. Henrik Zetterberg | CTAD 2024
Quanterix Top 5 2021 AAIC Abstracts
6:08
Quanterix Top 5 2021 AAIC Abstracts
AD/PD 2021 Round-up Discussion
26:15
AD/PD 2021 Round-up Discussion
High definition, precise cytokine profiling for COVID-19 with Simoa® Planar Array Technology
2:14
High definition, precise cytokine profiling for COVID-19 with Simoa® Planar Array Technology
The Quanterix Accelerator Lab: Powering Biomarker Testing for Axonal Degeneration
2:27
The Quanterix Accelerator Lab: Powering Biomarker Testing for Axonal Degeneration
Quanterix, Biomarkers for Life: Planar Array Product Overview
56:02
Quanterix, Biomarkers for Life: Planar Array Product Overview
Biomarkers for Neurodegenerative Research: Greg Warner , PhD
18:00
Biomarkers for Neurodegenerative Research: Greg Warner , PhD
Protein Biomarkers for IO Therapeutics - David Duffy, PhD
15:49
Protein Biomarkers for IO Therapeutics - David Duffy, PhD
SIMOA HD-X ANALYZER™
0:54
SIMOA HD-X ANALYZER™
THE SP-X IMAGING AND ANALYSIS SYSTEM
0:40
THE SP-X IMAGING AND ANALYSIS SYSTEM
Quanterix SP-X and Planar Array Technology
4:15
Quanterix SP-X and Planar Array Technology
Simoa Technology & SR-X Introduction Webinar
54:46
Simoa Technology & SR-X Introduction Webinar
December 19, 2017 SR-X Introduction Webinar
1:06:43
December 19, 2017 SR-X Introduction Webinar